Interaction of Tamoxifen and noise-induced damage to the cochlea

Hearing Research

Volumn 282, Issue 1-2, 2011, Pages 161-166

  Pillai, Jagan A ^a   Siegel, Jonathan H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; EAR PROTECTION; ENVIRONMENTAL EXPOSURE; HAIR CELL; HEARING; MALE; NOISE INJURY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

ANIMALS; AUDITORY THRESHOLD; COCHLEA; EVOKED POTENTIALS; GERBILLINAE; HEARING LOSS, NOISE-INDUCED; MALE; NOISE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TIME FACTORS;

EID: 82755160762     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2011.08.012     Document Type: Article

References (48)

1. Abdullaev I.F., Rudkouskaya A., Schools G.P., Kimelberg H.K., Mongin A.A. Pharmacological comparison of swelling-activated excitatory amino acid release and Cl-currents in cultured rat astrocytes. J. Physiol. 2006, 572:677-689.
2. Aran J.M. Current perspectives on inner ear toxicity. Otolaryngol. Head. Neck. Surg. 1995, 112:133-144.
3. Boettcher F.A., Henderson D., Gratton M.A., Danielson R.W., Byrne C.D. Synergistic interactions of noise and other ototraumatic agents. Ear. Hear. 1987, 8:192-212.
4. Bohne B.A. Mechanisms of noise damage in the inner ear. Effects of Noise on Hearing 1976, 41-68. Raven Press, New York. D. Henderson, R.P. Hamernik, D.S. Dosanjh, J.H. Mills (Eds.).
5. Bohne B.A., Harding G.W., Lee S.C. Death pathways in noise damaged outer hair cells. Hear. Res. 2007, 223:61-70.
6. Cardoso C.M., Custodio J.B., Almeida L.M., Moreno A.J. Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicol. Appl. Pharmacol. 2001, 176:145-152.
7. Charitidi K., Meltser I., Tahera Y., Canlon B. Functional responses of estrogen receptors in the male and female auditory system. Hear. Res. 2009, 252:71-78.
8. Chiodo A.A., Alberti P.W. Experimental, clinical and preventive aspects of ototoxicity. Eur. Arch. Otorhinolaryngol. 1994, 251:375-392.
9. Cody A.R., Johnstone B.M. Acoustic trauma: single neuron basis for the " half-octave shift" J. Acoust. Soc. Am. 1981, 70:707-711.
10. Cruz Silva M.M., Madeira V.M., Almeida L.M., Custodio J.B. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochim. Biophys. Acta 2000, 1464:49-61.
11. Custodio J.B., Moreno A.J., Wallace K.B. Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate. Toxicol. Appl. Pharmacol. 1998, 152:10-17.
12. Dallos P., Schoeny Z.G., Worthington D.W., Cheatham M.A. Some problems in the measurement of cochlear distortion. J. Acoust. Soc. Am. 1969, 46:356-361.
13. Duan D., Winter C., Cowley S., Hume J.R., Horowitz B. Molecular identification of a volume-regulated chloride channel. Nature 1997, 390:417-421.
14. Duan D.D. The ClC-3 chloride channels in cardiovascular disease. Acta Pharmacol. Sin. 2011, 32:675-684.
15. Hederstierna C., Hultcrantz M., Collins A., Rosenhall U. Hearing in women at menopause. Prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy. Acta Otolaryngol. 2007, 127:149-155.
16. Jenkins V., Low R., Mitra S. Hearing sensitivity in women following chemotherapy treatment for breast cancer: results from a pilot study. Breast 2009, 18:279-283.
17. Jordan V.C. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture. Ann. N. Y. Acad. Sci. 2001, 952:60-72.
18. Kilicdag E.B., Yavuz H., Bagis T., Tarim E., Erkan A.N., Kazanci F. Effects of estrogen therapy on hearing in postmenopausal women. Am. J. Obstet. Gynecol. 2004, 190:77-82.
19. Mandlekar S., Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6:469-477.
20. Marques D.M., Clark C.S., Hawkins J.E. Potentiation of ototoxic injury by noise and ototoxic antibiotic in guinea pigs. J. Acoust. Soc. Am. 1975, 57:S1. (Abstract).
21. Mattsson J.L. Ototoxicity: an argument for evaluation of the cochlea in safety testing in animals. Toxicol. Pathol. 2000, 28:137-141.
22. McClay E.F., McClay M.T., Monroe L., Jones J.A., Winski P.J. A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma. Melanoma Res. 2001, 11:309-313.
23. Mc Fadden The curious half octave shift: evidence for a basalward migration of the traveling wave envelope with increasing intensity. NATO ASI Series 1985, R.J. Salvi, D. Henderson, R.P. Hamernik, V. Colletti (Eds.).
24. Meltser I., Tahera Y., Simpson E., Hultcrantz M., Charitidi K., Gustafsson J.A., Canlon B. Estrogen receptor beta protects against acoustic trauma in mice. J. Clin. Invest. 2008, 118:1563-1570.
25. Morest D.K., Kim J., Potashner S.J., Bohne B.A. Long-term degeneration in the cochlear nerve and cochlear nucleus of the adult chinchilla following acoustic overstimulation. Microsc. Res. Tech. 1998, 41:205-216.
26. Motohashi R., Takumida M., Shimizu A., Konomi U., Fujita K., Hirakawa K., Suzuki M., Anniko M. Effects of age and sex on the expression of estrogen receptor alpha and beta in the mouse inner ear. Acta Otolaryngol. 2010, 130:204-214.
27. Neely S.T., Liu Z. EMAV: Otoacoustic Emission Averager. Tech Memo No. 17 1993, Boys Town National Research Hospital, Omaha.
28. Ohlemiller K.K., Siegel J.H. The effects of moderate cooling on gross cochlear potentials in the gerbil: basal and apical differences. Hear. Res. 1992, 63:79-89.
29. Ou H.C., Bohne B.A., Harding G.W. Noise damage in the C57BL/CBA mouse cochlea. Hear. Res. 2000, 145:111-122.
30. Overstreet E.H., Richter C.P., Temchin A.N., Cheatham M.A., Ruggero M.A. High-frequency sensitivity of the mature gerbil cochlea and its development. Audiol. Neurootol. 2003, 8:19-27.
31. Pearce M., Richter C.P., Cheatham M.A. A reconsideration of sound calibration in the mouse. J. Neurosci. Methods 2001, 106:57-67.
32. Perez E.A., Gandara D.R., Edelman M.J., O'Donnell R., Lauder I.J., DeGregorio M. Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies. Cancer Invest. 2003, 21:1-6.
33. Robinson S.P., Langan-Fahey S.M., Johnson D.A., Jordan V.C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos. 1991, 19:36-43.
34. Sardini A., Amey J.S., Weylandt K.H., Nobles M., Valverde M.A., Higgins C.F. Cell volume regulation and swelling-activated chloride channels. Biochim. Biophys. Acta 2003, 1618:153-162.
35. Schmiedt R.A. Acoustic distortion in the ear canal. I. Cubic difference tones: effects of acute noise injury. J. Acoust. Soc. Am. 1986, 79:1481-1490.
36. Shughrue P.J., Lane M.V., Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology 1997, 138:5476-5484.
37. Siegel J.H., Sikka R., Zeddies D.G., Gong Q. Intact explanted adult gerbil cochleae maintained at body temperature. Assoc. Res. Otolaryngol. 2001, Abs #21966. (Abstract).
38. Silva I., Mello L.E., Freymuller E., Haidar M.A., Baracat E.C. Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats. Neurosci. Lett. 2000, 291:183-186.
39. Simonoska R., Stenberg A.E., Duan M., Yakimchuk K., Fridberger A., Sahlin L., Gustafsson J.A., Hultcrantz M. Inner ear pathology and loss of hearing in estrogen receptor-beta deficient mice. J. Endocrinol. 2009, 201:397-406.
40. Spoendlin H. Primary structural changes in the organ of Corti after acoustic overstimulation. Acta Otolaryngol. 1971, 71:166-176.
41. Stenberg A.E., Wang H., Fish J., Schrott-Fischer A., Sahlin L., Hultcrantz M. Estrogen receptors in the normal adult and developing human inner ear and in Turner's syndrome. Hear. Res. 2001, 157:87-92.
42. Strachan D. Sudden sensorineural deafness and hormone replacement therapy. J. Laryngol. Otol. 1996, 110:1148-1150.
43. Thompson S.K., Zhu X., Frisina R.D. Estrogen blockade reduces auditory feedback in CBA mice. Otolaryngol. Head. Neck. Surg. 2006, 135:100-105.
44. Thorne P.R., Nuttall A.L. Laser Doppler measurements of cochlear blood flow during loud sound exposure in the guinea pig. Hear. Res. 1987, 27:1-10.
45. Thorne P.R., Nuttall A.L. Alterations in oxygenation of cochlear endolymph during loud sound exposure. Acta Otolaryngol. 1989, 107:71-79.
46. Trump D.L., Smith D.C., Ellis P.G., Rogers M.P., Schold S.C., Winer E.P., Panella T.J., Jordan V.C., Fine R.L. High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine. J. Natl. Cancer Inst. 1992, 84:1811-1816.
47. Veliskova J., Velisek L., Galanopoulou A.S., Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 2000, 41(Suppl. 6):S30-S35.
48. Yuan H., Bowlby D.A., Brown T.J., Hochberg R.B., MacLusky N.J. Distribution of occupied and unoccupied estrogen receptors in the rat brain: effects of physiological gonadal steroid exposure. Endocrinology 1995, 136:96-105.